Immunotherapy in Advanced Biliary Tract Cancers

Biliary tract cancers are rare tumors with a poor prognosis. Two-thirds of these primary liver malignancies are diagnosed at advanced stages where therapeutic options are limited. Whereas several molecular targeted therapies emerge in biliary tract cancers, immunotherapy is still investigational, th...

Full description

Bibliographic Details
Main Authors: Alice Boilève, Marc Hilmi, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, David Malka
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/7/1569